Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Marko, Ljubkovic"'
Autor:
Aleksandra Popovic, Jovana Drljaca, Milan Popovic, Dejan Miljkovic, Jasna Marinovic, Marko Ljubkovic, Nebojsa Kladar, Ivan Capo
Carnosine is known as a natural dipeptide, which inhibits the proliferation of tumor cells throughout its action on mitochondrial respiration and cell glycolysis. However, not much is known about its effects on the metabolism of healthy cells. We exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822a779108e7df2c81509cd403665a03
https://www.bib.irb.hr/1242087
https://www.bib.irb.hr/1242087
Autor:
Jasna Marinovic, Mélanie Gressette, Christophe Lemaire, Ivica Grković, Marko Ljubkovic, Marija Cavar, Darija Bakovic, Damir Fabijanić, Cristijan Bulat
Publikováno v:
Diabetes. 68:1924-1933
Chronic heart failure is a common complication in patients with type 2 diabetes mellitus (T2DM). T2DM is associated with disturbed metabolism of fat, which can result in excessive accumulation of lipids in cardiac muscle. In the current study, we ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1fc422bba987d46acfac2cc04a4048
https://doi.org/10.2337/db19-0423
https://doi.org/10.2337/db19-0423
Autor:
Jasenka Kraljević, Geir Bjørkøy, Marko Ljubkovic, Ingrid Åmellem, Arnar Flatberg, Ulrik Wisløff, José Bianco Nascimento Moreira, Jasna Marinovic, Simone Fenk, Martin Wohlwend
Publikováno v:
Progress in Cardiovascular Diseases. 62:193-202
The benefits of physical activity in cardiovascular diseases have long been appreciated. However, the molecular mechanisms that trigger and sustain the cardiac benefits of exercise are poorly understood, and it is anticipated that unveiling these mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7fe5deb6bbdc6f71aee5fbc4f7c2fb
https://doi.org/10.1016/j.pcad.2019.03.002
https://doi.org/10.1016/j.pcad.2019.03.002
Autor:
Jasna Marinovic, Marko Ljubkovic, Nadica Maltar-Strmecki, Jaksa Zanchi, Ivan Mihanovic, Cristijan Bulat
Publikováno v:
Progress in Cardiovascular Diseases
Revascularization therapies are essential for efficient treatment of acute coronary syndrome. Yet, besides rescuing the affected myocardium from excessive damage, reperfusion also inflicts additional injury. In this study, we assessed levels of react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83260178f0d6b5d02bed5565d4383a61
https://www.bib.irb.hr/1163718
https://www.bib.irb.hr/1163718
Autor:
François Guerrero, Marko Ljubkovic, Katja B. Ferenz, Dirk Mayer, Lisa Hetzel, Christian Mayer, Alfons Kreczy, Jürgen Linders, Michael Kirsch, Christelle Goanvec
Publikováno v:
Medicine and science in sports and exercise. 52(10)
For three decades, studies have demonstrated the therapeutic efficacy of perfluorocarbon (PFC) in reducing the onset of decompression trauma. However, none of these emulsion-based preparations are accepted for therapeutic use in the western world, ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c8226c94c223e1cf2a619cdf23c5c6
https://pubmed.ncbi.nlm.nih.gov/32251255
https://pubmed.ncbi.nlm.nih.gov/32251255
We would like to highlight that CRP is primarily an indicator of augmented inflammatory status, which is an active promotor of atherogenesis and trigger of acute coronary syndromes. Inflammatory process causing elevated CRP, even when primarily locat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358123f22daf353d65a14ac1f4b47812
https://www.bib.irb.hr/1084233
https://www.bib.irb.hr/1084233
Autor:
Dorotea Bozic, Marko Ljubkovic, Mislav Vrsalovic, Anita Jukić, Damir Fabijanić, Bruno Luksic, Duško Kardum, Tina Becic
Publikováno v:
Therapeutics and Clinical Risk Management. 13:933-938
AIM: Controversy exists concerning the relation between Helicobacter pylori (HP) infection and coronary artery disease (CAD). We aimed to examine the relationship between HP infection and severity of coronary atherosclerosis in patients with chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58339da4472863056ff43676a393d52d
https://doi.org/10.2147/tcrm.s142193
https://doi.org/10.2147/tcrm.s142193
Autor:
Jelena Gacesa-Popadic, Stevan Oluic, Miodrag Drapsin, Otto F. Barak, Aleksandar Klasnja, Marko Ljubkovic, Damir Lukac, Aleksandra Rakovac, Dea Karaba, Danijel Slavic, Vedrana Karan, Nada Naumovic, Maja Bogdan, Enis Garipi
Publikováno v:
Medical review. 70:445-448
Mitochondria are ubiquitous organelles of eukaryotic cells and they are the mayor site of generating energy in the form of adenosine triphoshate through the process of oxidative phosphorylation. Analysis and estimation of mitochondrial function is of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71e279afca0a8b7057679ff06df1cb1f
https://doi.org/10.2298/mpns1712445g
https://doi.org/10.2298/mpns1712445g
Autor:
Jasenka Kraljević, N Karanovic, Zeljko Dujic, Jasna Marinovic, Carl J. Lavie, Damir Fabijanić, Ulrik Wisløff, Marija Cavar, Darija Bakovic, C Bulat, Marko Ljubkovic
Publikováno v:
British Journal of Pharmacology. 173:1529-1540
Background and Purpose Trimetazidine, known as a metabolic modulator, is an anti-anginal drug used for treatment of stable coronary artery disease (CAD). It is proposed to act via modulation of cardiac metabolism, shifting the mitochondrial substrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::678c9bf7d099057dc4bfe9555f3398ae
https://doi.org/10.1111/bph.13454
https://doi.org/10.1111/bph.13454